BMC Cancer

1. YAO W, Dong S, Xu P, Zhong Z, et al
   A subgroup analysis of locally advanced nasopharyngeal carcinoma patients with small lymph nodes and large nodes using adaptive radiotherapy.
   BMC Cancer. 2025;25:1414.
   

   >> Share

   
   
2. MALTSEVA M, Klasen C, Wuerdemann N, Hannich M, et al
   Detection and natural history of HPV infection of oral cavity and tonsils - a systematic literature review.
   BMC Cancer. 2025;25:1405.
   

   >> Share

   
   

   
   Br J Cancer

3. WALKER RC, Breininger SP, Sharpe BP, Harrington J, et al
   Cancer-associated fibroblasts are associated with neo-adjuvant treatment response in oesophageal adenocarcinoma.
   Br J Cancer. 2025;133:633-647.
   

   >> Share

   
   
4. SPENDER LC, Watt DM, Baxter MA, Shuttleworth MK, et al
   AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma.
   Br J Cancer. 2025;133:709-722.
   

   >> Share

   
   
5. WU KP, Luo XQ, Li QQ, Yang HC, et al
   Efficacy and safety of induction immunotherapy plus chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a meta-analysis.
   Br J Cancer. 2025 Sep 5. doi: 10.1038/s41416-025-03169.
   

   >> Share

   
   

   
   Cancer Res

6. OLEINIK NV, Atilgan FC, Kassir MF, Lee HG, et al
   Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression.
   Cancer Res. 2025;85:3313-3334.
   

   >> Share

   
   

   
   Clin Cancer Res

7. HARRISON C, Blake AK, Su Y, Tang L, et al
   Contribution of Germline Predisposition to Pediatric Thyroid Cancer.
   Clin Cancer Res. 2025 Jun 27. doi: 10.1158/1078-0432.CCR-25-0631.
   

   >> Share

   
   

   
   Clin Nucl Med

8. BRUMENT M, Zanetta S, Drouet C
   18F-Fluorocholine PET/CT for the Staging and Follow-up of a Patient Suffering From Metastatic Parathyroid Carcinoma.
   Clin Nucl Med. 2025;50:e617-e620.
   

   >> Share

   
   
9. BILGIN C, Belge Bilgin G, Dundar B, Kapplinger JD, et al
   I-131 Uptake in a Benign Diaphragmatic Mesothelial Cyst Mimicking Thyroid Cancer Metastasis on Post-therapy SPECT/CT.
   Clin Nucl Med. 2025 Jul 1. doi: 10.1097/RLU.0000000000005923.
   

   >> Share

   
   
10. LIU J, Liao X, Pang Y, Lin Q, et al
    Squamous Cell Carcinoma of the Tonsil Unmasked by 68Ga-FAPI-46 PET/CT.
    Clin Nucl Med. 2025 Mar 28. doi: 10.1097/RLU.0000000000005866.
    

    >> Share

    
    
11. PERRONE E, Ghai K, Eismant A, Baum RP, et al
    TANDEM Peptide Receptor Radionuclide Therapy Using [ 225 Ac]Ac-/[ 177 Lu]Lu-DOTA-LM3 in a Patient With Parotid Gland Metastasis From Pancreatic Neuroendocrine Neoplasm.
    Clin Nucl Med. 2025;50:e605-e607.
    

    >> Share

    
    

    
    Dis Esophagus

12. 
    Correction to: The prevalence, nature and severity of oropharyngeal dysphagia in the acute post-operative phase following curative resection for esophageal cancer.
    Dis Esophagus. 2025;38:doaf074.
    

    >> Share

    
    

    
    Head Neck

13. BEN KRIDIS W, Khanfir A
    Efficacy and Safety of Adjuvant Capecitabine in Locoregionally Advanced Nasopharyngeal Carcinoma: A Meta-Analysis of Phase III Randomized Trials With Subgroup Analysis by Neoadjuvant Chemotherapy.
    Head Neck. 2025 Sep 3. doi: 10.1002/hed.70034.
    

    >> Share

    
    
14. THAI AA, Young RJ, Bressel M, Ma BBY, et al
    Examining CD103(+) Tissue-Resident Memory T Cells in Nasopharyngeal Carcinoma.
    Head Neck. 2025 Sep 3. doi: 10.1002/hed.70026.
    

    >> Share

    
    

    
    Hum Pathol

15. JIN J, Sun M, Yang X, Ding Z, et al
    Incidence of MSI-H esophageal carcinoma and related identification of genomic alterations: A multi-center real-world study.
    Hum Pathol. 2025;163:105878.
    

    >> Share

    
    

    
    J Clin Oncol

16. DOUGAN M, Dougan SK
    Second Mitochondrial Activator of Caspases Mimetics Accelerate Progression of Locally Advanced Head and Neck Cancer.
    J Clin Oncol. 2025 Sep 3:JCO2501024. doi: 10.1200/JCO-25-01024.
    

    >> Share

    
    
17. BOURHIS J, Licitra LF, Burtness B, Psyrri A, et al
    Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study.
    J Clin Oncol. 2025 Sep 3:JCO2500272. doi: 10.1200/JCO-25-00272.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

18. SENTHIL R
    Bevacizumab-Conjugated Curcumin Nanoparticles Promote Cytotoxicity and Apoptosis in Human Malignant Oral Keratinocytes In Vitro.
    J Oral Maxillofac Surg. 2025;83:1170-1178.
    

    >> Share

    
    
19. MOHAMED AK, Arce K, Nathan JM, Vierkant RA, et al
    Patient-Specific Titanium Implants Reduce Hardware-Related Complications Compared to Stock Reconstruction Plates for Virtually Guided Fibular Free Flaps in Head and Neck Reconstruction.
    J Oral Maxillofac Surg. 2025;83:1157-1169.
    

    >> Share

    
    

    
    Laryngoscope

20. MEGWALU UC, Ma Y, Divi V, Tian L, et al
    Mediators of Racial Disparities in Head and Neck Cancer Survival.
    Laryngoscope. 2025 Sep 5. doi: 10.1002/lary.70107.
    

    >> Share

    
    
21. GULATI A, Patel N, Kidane J, Perrin CE, et al
    Prevalence of Long-Term Dysphagia in Head and Neck Cancer Survivors Not Receiving Dysphagia Treatment.
    Laryngoscope. 2025 Sep 3. doi: 10.1002/lary.70085.
    

    >> Share

    
    

    
    Oral Oncol

22. KANA L, Chamma B, Robinette N, Cramer JD, et al
    Pre-treatment PET/CT for head and neck squamous cell carcinoma: secondary analysis of a clinical trial.
    Oral Oncol. 2025;169:107633.
    

    >> Share

    
    
23. DAI Y, Li W
    Comment on "Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD)" by Schroter et al.
    Oral Oncol. 2025;169:107640.
    

    >> Share

    
    
24. ANSARI E, Carrillo Minulina N, van Es RJJ, Dieleman FJ, et al
    Low skeletal muscle mass and not systemic inflammation is associated with complications after free forearm flap reconstruction in oral cancer patients.
    Oral Oncol. 2025;169:107628.
    

    >> Share

    
    
25. BARRETT TF, Apicelli AJ, Ramadan S, Pipkorn P, et al
    Management of HPV+ head and neck squamous cell carcinoma with unknown primary in the era of treatment de-escalation.
    Oral Oncol. 2025;169:107631.
    

    >> Share

    
    
26. BHAGIA P, Mukherjee A, Agarwal T, Giri S, et al
    Stroke risk after head and neck cancer diagnosis and treatment in a Real-World clinical cohort: Running title: Treatment in a Real-World clinical cohort.
    Oral Oncol. 2025;169:107599.
    

    >> Share

    
    
27. KLEEBAYOON A, Wiwanitkit V
    Semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD): correspondence.
    Oral Oncol. 2025;169:107645.
    

    >> Share

    
    
28. DUNN LA, Ho AL, Michel LS, Wong W, et al
    A phase 1/1b study of lenvatinib and cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2025;169:107524.
    

    >> Share

    
    
29. BATOOL S, Hansen EE, Sethi RKV, Rettig EM, et al
    Financial instability, insurance, and transportation influence timely head and neck cancer care in the United States: Patient and healthcare worker perspectives.
    Oral Oncol. 2025;169:107607.
    

    >> Share

    
    
30. PENG X, Xie Y, Liu Y
    Comment on "Prediction of clinical outcomes of immune checkpoint inhibitors in advanced head and neck cancer directly from histopathology slides using inferred transcriptomics".
    Oral Oncol. 2025;169:107644.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

31. WONG RSH, Sri Ram TM, Xia Y, Heng EH, et al
    Lobectomy Versus Total Thyroidectomy Across 2015 American Thyroid Association Low-to-Intermediate-Risk Papillary Thyroid Carcinoma.
    Otolaryngol Head Neck Surg. 2025 Sep 2. doi: 10.1002/ohn.70009.
    

    >> Share

    
    

    
    PLoS Genet

32. FURUDATE K, Kasai S, Yoshizawa T, Sasaki Y, et al
    Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma.
    PLoS Genet. 2025;21:e1011791.
    

    >> Share

    
    

    
    PLoS One

33. PACHECO MCD, Prado AHDR, da Costa DV, de Arantes LC, et al
    Survival of dental implants in irradiated head and neck cancer patients compared to non-irradiated patients: An umbrella review.
    PLoS One. 2025;20:e0324388.
    

    >> Share

    
    
34. OCCOMORE-KENT LC, Stavropoulou C, Ward EC, Elkington C, et al
    Training and competency frameworks used in the preparation of healthcare professionals for head and neck cancer screening: A scoping review protocol.
    PLoS One. 2025;20:e0330664.
    

    >> Share

    
    
35. KHAN A, Fawzy WMS, Habib SS, Sultan M, et al
    Integrated comparative analysis of T-staging of laryngeal carcinoma on parallel versus non-parallel vocal cord CT planes with its potential treatment pitfalls.
    PLoS One. 2025;20:e0330389.
    

    >> Share

    
    

    
    Radiother Oncol

36. GAU M, Alfaraj FA, Huang SH, O'Sullivan B, et al
    Unilateral vs bilateral neck irradiation: The importance of careful patient selection in tailoring radiation therapy for lateralized palatine-tonsil and non-palatine-tonsil oropharyngeal carcinoma.
    Radiother Oncol. 2025;210:111049.
    

    >> Share

    
    
37. CHEUNG BMF, Yuen KK, Luk MY, Leung DKC, et al
    Lymphocyte nadir and recovery dynamics for locally advanced thoracic malignancies undergoing concurrent chemo-irradiation: Establishment of organs-at-risk constraints.
    Radiother Oncol. 2025;210:111009.
    

    >> Share

    
    

    
    Thyroid

38. CHEN T, Li X, Hong D, Yin L, et al
    Targeting B7-H3 in Cancer-Associated Fibroblasts Using Nanosystems Suppresses Anaplastic Thyroid Carcinoma Progression.
    Thyroid. 2025 Sep 3. doi: 10.1177/10507256251372644.
    

    >> Share

    
    
39. ZHANG J, Castroneves LA, Lindsey SC, Han R, et al
    Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.
    Thyroid. 2025 Sep 3. doi: 10.1177/10507256251372196.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share